Rubius Therapeutics Inc (RUBY) Insider Trading
- $6,624,680.00
- $5,184,039.75
- Feb. 24, 2023
- David R Epstein
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 24, 2023 | CEO | 10,385 | $0.13 | Sell | $1,350.05 | |
| Feb. 1, 2023 | CEO | 3,878 | $0.25 | Sell | $969.50 | |
| Jan. 31, 2023 | Insider | 2,593 | $0.24 | Sell | $622.32 | |
| Jan. 31, 2023 | Director | 7,240 | $0.24 | Sell | $1,737.60 | |
| Aug. 10, 2022 | COO | 5,737 | $0.80 | Sell | $4,589.60 | |
| April 21, 2022 | Director | 30,000 | $1.44 | Buy | $43,200.00 | |
| Feb. 1, 2022 | Insider | 2,732 | $6.57 | Sell | $17,949.24 | |
| Feb. 1, 2022 | CEO | 6,730 | $6.57 | Sell | $44,216.10 | |
| March 19, 2021 | Major Shareholder | 210,000 | $29.00 | Buy | $6,090,000.00 | |
| March 15, 2021 | Insider | 25,000 | $20.24 | Sell | $506,000.00 | |
| Feb. 10, 2021 | Director | 7,404 | $14.79 | Sell | $109,505.16 | |
| Feb. 8, 2021 | Director | 89,233 | $14.88 | Sell | $1,327,787.04 | |
| April 22, 2020 | Insider | 19,000 | $5.52 | Buy | $104,880.00 | |
| April 14, 2020 | CEO | 21,000 | $4.70 | Buy | $98,700.00 | |
| March 17, 2020 | Director | 5,000 | $3.76 | Buy | $18,800.00 | |
| March 13, 2020 | Director | 10,000 | $3.91 | Buy | $39,100.00 | |
| Dec. 16, 2019 | Insider | 48,000 | $13.48 | Sell | $647,040.00 | |
| Oct. 14, 2019 | Director | 7,500 | $9.25 | Sell | $69,375.00 | |
| Sept. 17, 2019 | Insider | 48,000 | $10.11 | Sell | $485,280.00 | |
| July 15, 2019 | Director | 7,500 | $14.94 | Sell | $112,050.00 | |
| June 19, 2019 | Insider | 47,757 | $14.02 | Sell | $669,553.14 | |
| April 15, 2019 | Director | 7,500 | $17.57 | Sell | $131,775.00 | |
| April 8, 2019 | President | 2,100 | $20.00 | Sell | $42,000.00 | |
| April 5, 2019 | President | 12,596 | $20.00 | Sell | $251,920.00 | |
| March 15, 2019 | Insider | 48,000 | $15.84 | Sell | $760,320.00 | |
| July 20, 2018 | Director | 10,000 | $23.00 | Buy | $230,000.00 |
Insiders are both buying and selling Rubius Therapeutics Inc stock.
The insider traders at Rubius Therapeutics Inc are: David R Epstein, Christopher L Carpenter, Robert Langer, Pablo J Cagnoni, Dannielle Appelhans, Torben Straight Nissen, Maiken Keson-Brookes, Ventures Fund Iv Gene Flagship, Francis M Cuss, Laurence A Turka, and Christina M Coughlin
The most active insider trader at Rubius Therapeutics Inc is David R Epstein with 5 trades.
Christopher L Carpenter has sold the most Rubius Therapeutics Inc stock with a total value of $3,209,233.14.
Ventures Fund Iv Gene Flagship has bought the most Rubius Therapeutics Inc stock with a total value of $12,180,000.00.
The most recent insider trade for Rubius Therapeutics Inc was on Feb. 24, 2023.
The single biggest insider buy for Rubius Therapeutics Inc was from Ventures Fund Iv Gene Flagship with a total value of $6,090,000.00 on March 19, 2021.
The single biggest insider sell for Rubius Therapeutics Inc was from David R Epstein with a total value of $1,327,787.04 on Feb. 8, 2021.